Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11099786rdf:typepubmed:Citationlld:pubmed
pubmed-article:11099786lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:11099786lifeskim:mentionsumls-concept:C0949653lld:lifeskim
pubmed-article:11099786lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:11099786pubmed:issue3lld:pubmed
pubmed-article:11099786pubmed:dateCreated2001-1-26lld:pubmed
pubmed-article:11099786pubmed:abstractTextIn the present study, effects of the alpha(2)- and beta-adrenoceptor agonists clonidine and isoproterenol on astrocytes in astroglial/neuronal cocultures from rat cerebral cortex were evaluated. The calcium- and potassium-sensitive dyes fura-2 and potassium-binding benzofuran isophtalate (PBFI) were used to study alterations in intracellular concentrations of calcium ([Ca(2+)](i)) and potassium ([K(+)](i)), respectively, while the perforated patch clamp technique was used to analyze transmembrane currents. Exposure to isoproterenol or clonidine elicited an immediate increase in [Ca(2+)](i) that was totally abolished in calcium-free extracellular media. Isoproterenol also decreased [K(+)](i), but clonidine did not. The reduction in [K(+)](i) was inhibited in Ca(2+)-free media. As evaluated with the perforated patch technique, isoproterenol (10(-6)-10(-4) M) induced a slowly developing and long lasting outward current that also was totally abolished in calcium-free buffer. This current was blocked by external tetraethylammonium (TEA, 10 mM) and charybdotoxin (ChTX, 10 nM), but was not affected by apamin (50 nM). The current-to-voltage (I-V) relationships for the isoproterenol-induced currents showed a markedly negative reversal potential, -96 mV+/-7, (mean+/-S.D., n=5). These results suggest that the stimulation of astroglial beta-adrenoceptors by isoproterenol opens calcium-activated potassium channels (K((Ca))). Preincubation with forskolin significantly increased the isoproterenol-induced currents compared with controls, indicating that the opening of astroglial K((Ca)) channels after beta-adrenergic stimulation not only depends on [Ca(2+)](i) but also synergistically involves the cAMP transduction system to which beta-adrenoceptors are known to be positively coupled.lld:pubmed
pubmed-article:11099786pubmed:languageenglld:pubmed
pubmed-article:11099786pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11099786pubmed:citationSubsetIMlld:pubmed
pubmed-article:11099786pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11099786pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11099786pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11099786pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11099786pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11099786pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11099786pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11099786pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11099786pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11099786pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11099786pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11099786pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11099786pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11099786pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11099786pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11099786pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11099786pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11099786pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11099786pubmed:statusMEDLINElld:pubmed
pubmed-article:11099786pubmed:monthMarlld:pubmed
pubmed-article:11099786pubmed:issn0197-0186lld:pubmed
pubmed-article:11099786pubmed:authorpubmed-author:NilssonMMlld:pubmed
pubmed-article:11099786pubmed:authorpubmed-author:SinclairJJlld:pubmed
pubmed-article:11099786pubmed:authorpubmed-author:HanssonEElld:pubmed
pubmed-article:11099786pubmed:authorpubmed-author:JardemarkKKlld:pubmed
pubmed-article:11099786pubmed:authorpubmed-author:MuydermanHHlld:pubmed
pubmed-article:11099786pubmed:issnTypePrintlld:pubmed
pubmed-article:11099786pubmed:volume38lld:pubmed
pubmed-article:11099786pubmed:ownerNLMlld:pubmed
pubmed-article:11099786pubmed:authorsCompleteYlld:pubmed
pubmed-article:11099786pubmed:pagination269-76lld:pubmed
pubmed-article:11099786pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:11099786pubmed:meshHeadingpubmed-meshheading:11099786...lld:pubmed
pubmed-article:11099786pubmed:meshHeadingpubmed-meshheading:11099786...lld:pubmed
pubmed-article:11099786pubmed:meshHeadingpubmed-meshheading:11099786...lld:pubmed
pubmed-article:11099786pubmed:meshHeadingpubmed-meshheading:11099786...lld:pubmed
pubmed-article:11099786pubmed:meshHeadingpubmed-meshheading:11099786...lld:pubmed
pubmed-article:11099786pubmed:meshHeadingpubmed-meshheading:11099786...lld:pubmed
pubmed-article:11099786pubmed:meshHeadingpubmed-meshheading:11099786...lld:pubmed
pubmed-article:11099786pubmed:meshHeadingpubmed-meshheading:11099786...lld:pubmed
pubmed-article:11099786pubmed:meshHeadingpubmed-meshheading:11099786...lld:pubmed
pubmed-article:11099786pubmed:meshHeadingpubmed-meshheading:11099786...lld:pubmed
pubmed-article:11099786pubmed:meshHeadingpubmed-meshheading:11099786...lld:pubmed
pubmed-article:11099786pubmed:meshHeadingpubmed-meshheading:11099786...lld:pubmed
pubmed-article:11099786pubmed:meshHeadingpubmed-meshheading:11099786...lld:pubmed
pubmed-article:11099786pubmed:meshHeadingpubmed-meshheading:11099786...lld:pubmed
pubmed-article:11099786pubmed:meshHeadingpubmed-meshheading:11099786...lld:pubmed
pubmed-article:11099786pubmed:meshHeadingpubmed-meshheading:11099786...lld:pubmed
pubmed-article:11099786pubmed:meshHeadingpubmed-meshheading:11099786...lld:pubmed
pubmed-article:11099786pubmed:meshHeadingpubmed-meshheading:11099786...lld:pubmed
pubmed-article:11099786pubmed:meshHeadingpubmed-meshheading:11099786...lld:pubmed
pubmed-article:11099786pubmed:meshHeadingpubmed-meshheading:11099786...lld:pubmed
pubmed-article:11099786pubmed:meshHeadingpubmed-meshheading:11099786...lld:pubmed
pubmed-article:11099786pubmed:meshHeadingpubmed-meshheading:11099786...lld:pubmed
pubmed-article:11099786pubmed:meshHeadingpubmed-meshheading:11099786...lld:pubmed
pubmed-article:11099786pubmed:meshHeadingpubmed-meshheading:11099786...lld:pubmed
pubmed-article:11099786pubmed:meshHeadingpubmed-meshheading:11099786...lld:pubmed
pubmed-article:11099786pubmed:meshHeadingpubmed-meshheading:11099786...lld:pubmed
pubmed-article:11099786pubmed:year2001lld:pubmed
pubmed-article:11099786pubmed:articleTitleActivation of beta-adrenoceptors opens calcium-activated potassium channels in astroglial cells.lld:pubmed
pubmed-article:11099786pubmed:affiliationInstitute of Neurobiology and Institute of Clinical Neuroscience, Göteborg University, Box 420, SE-405 30, Göteborg, Sweden.lld:pubmed
pubmed-article:11099786pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11099786pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed